Bay Navigator

Advance Prescriptions for Oral COVID-19 Antiviral Medicines

Guidance for relevant appropriately qualified prescribers and pharmacists.

On 14 July 2022, the Minister for COVID-19 Response Hon Dr Ayesha Verrall announced that eligible patients could receive an advance (“back pocket”) prescription for the following oral COVID-19 antiviral medicines - Nirmatrelvir with ritonavir (Paxlovid) and Molnupiravir (Lagevrio).

The purpose of this guidance document is to:
1. Clarify when and why this may be appropriate; and
2. Provide additional guidance and support for prescribers and pharmacists.

Click here to read the document in full

Back to latest